Los Tratamientos Herbarios Pueden Afectar el Examen de Detección Temprana para el Cáncer de la Próstata
Antígeno específico de la próstata (PSA)
Information about prostate cancer screening and follow up care using the various prostate specific antigen (PSA) tests.
Entendiendo su informe de patología: Prostate Cancer

News
Over-Diagnosis Risk From Prostate Cancer Screening

May 5, 2015 - Screening for prostate cancer does not reduce the mortality rate after seven to 10 years' follow-up, according to study results released online March 18 in advance of publication in the March 26 issue of the New England Journal of Medicine, while a second study in the same issue concludes that prostate-specific antigen-based screening does reduce mortality but runs the risk of over-diagnosis.



I Wish You Knew

The Controversy of Screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.


OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información



OncoLink Cancer Treatment and Resources